Headaches in children and adolescents. A blueprint for pharmacologic and nonpharmacologic approaches.
Rowley
Susan M
SM
Blank Children's Hospital in Des Moines, Iowa, USA.
D000293:Adolescent; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004876:Ergot Alkaloids / Q000627:therapeutic use; D005260:Female; D006261:Headache / Q000145:classification / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009722:Nurse Practitioners; D018579:Patient Selection; D011320:Primary Health Care / Q000379:methods; D011322:Primary Prevention; D012064:Relaxation Therapy; D012307:Risk Factors
D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000927:Anticonvulsants; D000929:Antidepressive Agents, Tricyclic; D002121:Calcium Channel Blockers; D004876:Ergot Alkaloids; D006634:Histamine H1 Antagonists